INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 178 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $36 | -34.5% | 70 | +100.0% | 0.00% | – |
| Q4 2022 | $55 | -99.7% | 35 | -99.6% | 0.00% | – |
| Q3 2022 | $16,000 | -11.1% | 9,335 | -11.1% | 0.00% | – |
| Q2 2022 | $18,000 | -45.5% | 10,499 | +12.9% | 0.00% | – |
| Q1 2022 | $33,000 | -29.8% | 9,300 | -2.1% | 0.00% | – |
| Q4 2021 | $47,000 | -29.9% | 9,500 | +2.2% | 0.00% | – |
| Q3 2021 | $67,000 | -22.1% | 9,300 | 0.0% | 0.00% | – |
| Q2 2021 | $86,000 | 0.0% | 9,300 | 0.0% | 0.00% | – |
| Q1 2021 | $86,000 | +4.9% | 9,300 | 0.0% | 0.00% | – |
| Q4 2020 | $82,000 | -24.1% | 9,300 | 0.0% | 0.00% | – |
| Q3 2020 | $108,000 | -61.2% | 9,300 | -9.7% | 0.00% | -100.0% |
| Q2 2020 | $278,000 | +265.8% | 10,300 | +0.5% | 0.00% | – |
| Q1 2020 | $76,000 | +145.2% | 10,250 | +10.2% | 0.00% | – |
| Q4 2019 | $31,000 | +63.2% | 9,300 | 0.0% | 0.00% | – |
| Q3 2019 | $19,000 | -29.6% | 9,300 | 0.0% | 0.00% | – |
| Q2 2019 | $27,000 | -22.9% | 9,300 | 0.0% | 0.00% | – |
| Q1 2019 | $35,000 | -5.4% | 9,300 | 0.0% | 0.00% | – |
| Q4 2018 | $37,000 | -28.8% | 9,300 | 0.0% | 0.00% | – |
| Q3 2018 | $52,000 | -38.8% | 9,300 | -57.3% | 0.00% | – |
| Q2 2018 | $85,000 | -17.5% | 21,800 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $103,000 | +14.4% | 21,800 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $90,000 | -34.8% | 21,800 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $138,000 | -19.3% | 21,800 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $171,000 | – | 21,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|